Conjugates of human insulin and analogues with sustained hypoglycemia and high receptor binding
A technology of recombinant human insulin and conjugates, applied in the direction of insulin, animal/human proteins, hormone peptides, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0030] Example 1. Recombinant expression and purification of recombinant human insulin analog (DesB30)
[0031] In this example, according to the amino acid sequence of the human insulin analog DesB30 (Seq ID NO.2), the corresponding cDNA sequence of the yeast preferred codon is designed, which contains the leader peptide sequence EVFK and the middle short C peptide AAK corresponding to The cDNA sequence contains the restriction endonuclease Xho I and Not I sites at the 5' end and the 3' end respectively. The entire cDNA sequence is as follows (Seq ID NO.3):
[0032]CTCGAGAAGAGAGAAGTCTTCAAGTTTGTTAACCAACATTTGTGTGGTTCCCACTTGGTTGAAGCTTTGTACTTGGTTTGTGGTGAAAGAGGTTTCTTCTACACTCCAAAGGCTGCTAAGGGTATCGTTGAACAATGTTGTACTTCCATCTGTTCCTTGTACCAATTGGAAAACTACTGTAACTGATAAGCGGCCGC,委托宝生物(大连)有限公司人工合成Seq ID NO.3的cDNA基因片段,并嵌入pUC18载体且命名为pUC18-DesB30。 Plasmid pUC18-DesB30 and expression vector plasmid pICZαA were double-digested with restriction endonucleases Xho I and Not I, recovered by gel, ligated ...
example 2
[0037] Example 2. Preparation of recombinant human insulin analogue conjugate (DesB30-5K)
[0038] Take 100ml of recombinant human insulin analog (DesB30) solution (containing 20mmol / L Tris-HCl) with a concentration of 2mg / ml, adjust the pH to 10.5, stir at 100rpm at room temperature, first add mPEG-SPA ( The molecular weight is 5K, purchased from Beijing Jiankai Technology Co., Ltd.), after reacting for 30 minutes, add mPEG-SPA at a molar mass ratio of 1:1.5, continue to react for 30 minutes, and adjust the pH to 3.0 with 1% trifluoroacetic acid to terminate the reaction , The modified sample was subjected to reverse-phase preparative C18 column chromatography to separate and remove unmodified DesB30, free PEG molecules, and other conjugates not modified at the B29 position. The separation conditions are: liquid A is 0.1% trifluoroacetic acid and 5% acetonitrile, liquid B is 0.1% trifluoroacetic acid and 95% acetonitrile, the DesB30-5K conjugate is collected by linear gradien...
example 3
[0039] Example 3. Preparation of recombinant human insulin analogue conjugate (DesB30-10K)
[0040] Take 100ml of recombinant human insulin analogue (DesB30) solution (containing 20mmol / L Tris-HCl) with a concentration of 2mg / ml, adjust the pH to 10.5, stir at 100rpm at room temperature, first add mPEG-SPA ( The molecular weight is 10K, purchased from Beijing Jiankai Technology Co., Ltd.), after reacting for 30 minutes, add mPEG-SPA at a molar mass ratio of 1:2, continue to react for 30 minutes, adjust the pH to 3.0 with 1% TFA to terminate the reaction, modify Afterwards, the sample was subjected to reverse-phase preparative C18 column chromatography to separate and remove unmodified DesB30, free PEG molecules, and other conjugates not modified at the B29 position. The separation conditions are: liquid A is 0.1% trifluoroacetic acid and 5% acetonitrile, liquid B is 0.1% trifluoroacetic acid and 95% acetonitrile, the DesB30-10K conjugate is collected by linear gradient elution...
PUM
Property | Measurement | Unit |
---|---|---|
molecular weight | aaaaa | aaaaa |
molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com